Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Economic Adulteration Underscored In GAO Memory Supplements Study

Nov 16 2018

• By Eileen Francis

Government Accountability Office

Related Content

Gingko Supplement Adulteration Points To Broader Problem For FDA – CSPI

May 15 2018

Sports Nutrition Products Mark Start Of FDA’s Picamilon Enforcement

Dec 07 2015

Supplement Claims Targeting Elderly, Weight Conscious Top FTC Priorities

May 24 2017

GAO Report Casts Shade On Sunscreen Ingredients' Chances With FDA

Nov 21 2017

Additional Topics

United States Dietary Supplements Regulation Advertising, Marketing & Sales FDA Consumer

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window